Publications
Retreatment or prolonged antiviral therapy in severe acute respiratory syndrome Coronavirus-2 infection among immunocompromised patients during 2022–2023: A nationwide claims-based cohort study in Japan
Yamamoto, S., Ikeuchi, K., Saito, M., Okushin, K., Kado, A., Kitaura, S., Okugawa, S., & Tsutsumi, T. (2025). Journal of Infection and Chemotherapy, 31(11), 102830.
Invasive Rhino-Orbital Mucormycosis in a Middle-Aged COVID-19 Patient: A Case Report
Chowdhury, F., Kundu, A., Aman, S., Arafat, M., Bari, M., & Miah, M. (2025). Journal of Bangladesh College of Physicians and Surgeons, 43(4), 298-302.
Comparative effectiveness of antiviral treatment on household transmission of SARS-CoV-2: a retrospective cohort study using administrative data
Ikeuchi, K., Saito, M., Okushin, K., Arisato, Y., Kishida, T., Matsumoto, S., Kado, A., Yotsuyanagi, H., & Tsutsumi, T. (2025). BMC Infectious Diseases, 25(1).
Accurate measurement of viral clearance in early phase antiviral studies in COVID-19
Wongnak, P., Watson, J., Jittamala, P., Schilling, W., Seers, T., Leopold, S., & White, N. (2025). The Journal of Infectious Diseases, jiaf442.
Use of Ursodeoxycholic Acid and the Risk of Severe Coronavirus Disease 2019 in Elderly Patients with Viral Hepatitis.
Okushin, K., Ikeuchi, K., Saito, M., Kishida, T., Kado, A., Fujishiro, M., Moriya, K., Yotsuyanagi, H., Koike, K., & Tsutsumi, T. (2025). Internal Medicine (Tokyo, Japan), 64(15), 2301-2306.
Unveiling sub-populations in critical care settings: a real-world data approach in COVID-19
Anderson, W., Gould, R., Patil, N., Mohr, N., Dodd, K., Boyce, D., Dasher, P., Guerin, P., Khan, R., Cheruku, S., Kumar, V., Mathé, E., Mehta, A., Michelson, A., Williams, A., Heavner, S., & Podichetty, J. (2025). Frontiers in Public Health, 13, 1544904.
Mass testing for discovery and control of COVID-19 outbreaks in adult social care: an observational study and cost-effectiveness analysis of 14 805 care homes in England
Chen, S., Creswell, R., Hounsell, R., Cantrell, L., Bajaj, S., Dahal, P., Tsui Lok Hei, J., Kolade, O., Amswych, M., Naidoo, R., Fowler, T., Hopkins, S., Stepniewska, K., Voysey, M., White, L., Shretta, R., & Lambert, B. (2025). BMJ Public Health, 3(1).
Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)
Jittamala, P., Boyd, S., Schilling, W., Watson, J., Ngamprasertchai, T., Siripoon, T., Luvira, V., Batty, E., Wongnak, P., Esper, L., Almeida, P., Cruz, C., Ascencao, F., Aguiar, R., Ghanchi, N., Callery, J., Singh, S., Kruabkontho, V., Ngernseng, T., … White, N. (2025). EClinicalMedicine, 80.
Molnupiravir clinical trial simulation suggests that polymerase chain reaction underestimates antiviral potency against SARS-CoV-2
Esmaeili, S., Owens, K., Standing, J., Lowe, D., Zhang, S., Watson, J., Schilling, W., Wagoner, J., Polyak, S., & Schiffer, J. (2025). In medRxiv.
COVID-19 testing and reporting behaviours in England across different sociodemographic groups: a population-based study using testing data and data from community prevalence surveillance surveys
Bajaj, S., Chen, S., Creswell, R., Naidoo, R., Tsui, J.-H., Kolade, O., Nicholson, G., Lehmann, B., Hay, J., Kraemer, M., Aguas, R., Donnelly, C., Fowler, T., Hopkins, S., Cantrell, L., Dahal, P., White, L., Stepniewska, K., Voysey, M., … White, L. (2024). The Lancet Digital Health, 6(11), e778 - e790.
Long Covid: a global health issue – a prospective, cohort study set in four continents
Pazukhina, E., Garcia-Gallo, E., Reyes, L., Kildal, A., Jassat, W., Dryden, M., Holter, J., Chatterjee, A., Gomez, K., Søraas, A., Puntoni, M., Latronico, N., Bozza, F., Edelstein, M., Gonçalves, B., Kartsonaki, C., Kruglova, O., Gaião, S., Chow, Y., … Sigfrid, L. (2024). BMJ Global Health, 9(10).
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial
Schilling, W., Mukaka, M., Callery, J., Llewelyn, M., Cruz, C., Dhorda, M., Ngernseng, T., Waithira, N., Ekkapongpisit, M., Watson, J., Chandna, A., Nelwan, E., Hamers, R., Etyang, A., Beg, M., Sow, S., Yavo, W., Allabi, A., Basnyat, B., … Tarning, J. (2024). PLoS Medicine, 21(9).
Understanding COVID-19 testing behaviour in England through a sociodemographic lens: a population based study
Bajaj, S., Chen, S., Creswell, R., Naidoo, R., Tsui, J., Nicholson, G., Hay, J., Kraemer, M., Aguas, R., Donnelly, C., Cantrell, L., Dahal, P., White, L., Stepniewska, K., Voysey, M., & Lambert, B. (2024). Lancet Digital Health.
An evaluation of the national testing response during the COVID-19 pandemic in England: a multistage mixed-methods study protocol
Naidoo, R., Lambert, B., Voysey, M., Shretta, R., Keene, C., Wanat, M., Andersen-Waine, B., Dahal, P., Stepniewska, K., Hounsell, R., Molyneux, S., Pinto-Duschinsky, S., Rowe, E., Yenidogan, G., Fowler, T., White, L., & Consortium, E.-O. (2024). BMJ Open, 14(6).
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)
Wongnak, P., Schilling, W., Jittamala, P., Boyd, S., Luvira, V., Siripoon, T., Ngamprasertchai, T., Batty, E., Singh, S., Kouhathong, J., Pagornrat, W., Khanthagan, P., Hanboonkunupakarn, B., Poovorawan, K., Mayxay, M., Chotivanich, K., Imwong, M., Pukrittayakamee, S., Ashley, E., … Watson, J. (2024). Lancet Infectious Diseases, 24(9), P953 - 963.
Comparison of WHO versus national COVID-19 therapeutic guidelines across the world: not exactly a perfect match
Cokljat, M., Cruz, C., Carrara, V., Puttaraska, K., Capriglioni, C., Insaurralde, S., Rousseau-Portalis, M., Roldan, A., Watson, J., Tarning, J., White, N., & Guerin, P. (2024). BMJ Global Health, 9(4), e014188.
Obesity differs from diabetes mellitus in antibody and T-cell responses post-COVID-19 recovery
Ali, M., Longet, S., Neale, I., Rongkard, P., Chowdhury, F., Hill, J., Brown, A., Laidlaw, S., Tipton, T., Hoque, A., Hassan, N., Hackstein, C.-P., Adele, S., Delowar Akther, H., Abraham, P., Paul, S., Rahman, M., Alam, M., Parvin, S., … Dunachie, S. (2024). Clinical and Experimental Immunology, 218(1), 78-92.
Decision to self-isolate during the COVID-19 pandemic in the UK: a rapid scoping review.
Keene, C., Dickinson, S., Naidoo, R., Andersen-Waine, B., Ferguson-Lewis, A., Polner, A., Amswych, M., White, L., Molyneux, S., Wanat, M., & EY-Oxford Health Analytics Consortium. (2024). BMJ Open, 14(3), e084437.
The relationship between viral clearance rates and disease progression in early symptomatic COVID-19: a systematic review and meta-regression analysis.
Singh, S., Boyd, S., Schilling, W., Watson, J., Mukaka, M., & White, N. (2024). The Journal of Antimicrobial Chemotherapy, 79(5), 935-945.
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
Luvira, V., Schilling, W., Jittamala, P., Watson, J., Boyd, S., Siripoon, T., Ngamprasertchai, T., Almeida, P., Ekkapongpisit, M., Cruz, C., Callery, J., Singh, S., Tuntipaiboontana, R., Kruabkontho, V., Ngernseng, T., Tubprasert, J., Abdad, M., Keayarsa, S., Madmanee, W., … White, N. (2024). BMC Infectious Disease, 24(1).
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)
Wongnak, P., Schilling, W., Jittamala, P., Boyd, S., Luvira, V., Siripoon, T., Ngamprasertchai, T., Batty, E., Singh, S., Kouhathong, J., Pagornrat, W., Khanthagan, P., Hanboonkunupakarn, B., Poovorawan, K., Mayxay, M., Chotivanich, K., Imwong, M., Pukrittayakamee, S., Ashley, E., … Watson, J. (2024). In medRxiv.
Mass testing for discovery and control of COVID-19 outbreaks in adult social care: an observational study and cost-effectiveness analysis of 14,805 care homes in England
Chen, S., Creswell, R., Hounsell, R., Cantrell, L., Bajaj, S., Dahal, P., Tsui, L., Kolade, O., Amswych, M., Naidoo, R., Fowler, T., Hopkins, S., Stepniewska, K., Voysey, M., White, L., Shretta, R., & Lambert, B. (2024). In medRxiv.
Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)
Jittamala, P., Boyd, S., Schilling, W., Watson, J., Ngamprasertchai, T., Siripoon, T., Luvira, V., Batty, E., Wongnak, P., Esper, L., Almeida, P., Cruz, C., Ascencao, F., Aguiar, R., Ghanchi, N., Callery, J., Singh, S., Kruabkontho, V., Ngernseng, T., … White, N. (2024). In medRxiv.
COVID-19 presenting as Acute abdomen- a study of 3 cases
Paul, S., Islam, K., Chowdhury, F., & Chowdhury, F. (2023). Journal of Bangladesh College of Physicians and Surgeons, 41(4), 320-324.
Innovative method for rapid detection of falsified COVID-19 vaccines through unopened vials using handheld Spatially Offset Raman Spectroscopy (SORS)
Mosca, S., Lin, Q., Stokes, R., Bharucha, T., Gangadharan, B., Clarke, R., Gomez Fernandez, L., Deats, M., Walsby-tickle, J., Yohan Arman, B., Chunekar, S., Patil, K., Gairola, S., Van Assche, K., Dunachie, S., Merchant, H., Kuwana, R., Maes, A., McCullagh, J., … Matousek, P. (2023). Vaccine, 41(47), 6960-6968.